Skip to main content
OpenTrials

Clinical trial condition

Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8

Explore clinical trials studying Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8. Study availability and eligibility vary by location and protocol.

8 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8 trial results

Recruiting

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

NCT03801876

Conditions
Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, +10 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
View all 96 locations
View Trial Details
Not Yet Recruiting

Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesophageal Cancer Survivors, PRECISE Trial

NCT07439484

Conditions
Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage I Gastric Cancer AJCC v8, +9 more
Locations
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

NCT04460937

Conditions
Adenocarcinoma Of Esophagus, Brain Diseases, Brain Neoplasms, +80 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details

Related conditions